Lara Longpre - Net Worth and Insider Trading

Lara Longpre Net Worth

The estimated net worth of Lara Longpre is at least $3 Million dollars as of 2024-06-06. Lara Longpre is the CHIEF DEVELOPMENT OFFICER of Mirum Pharmaceuticals Inc and owns about 104,407 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $3 Million. Details can be seen in Lara Longpre's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lara Longpre has not made any transactions after 2024-02-02 and currently still holds the listed stock(s).

Transaction Summary of Lara Longpre

To

Lara Longpre Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lara Longpre owns 1 companies in total, including Mirum Pharmaceuticals Inc (MIRM) .

Click here to see the complete history of Lara Longpre’s form 4 insider trades.

Insider Ownership Summary of Lara Longpre

Ticker Comapny Transaction Date Type of Owner
MIRM Mirum Pharmaceuticals Inc 2024-02-02 Chief Development Officer

Lara Longpre Latest Holdings Summary

Lara Longpre currently owns a total of 1 stock. Lara Longpre owns 104,407 shares of Mirum Pharmaceuticals Inc (MIRM) as of February 2, 2024, with a value of $3 Million.

Latest Holdings of Lara Longpre

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MIRM Mirum Pharmaceuticals Inc 2024-02-02 104,407 26.30 2,745,904

Holding Weightings of Lara Longpre


Lara Longpre Form 4 Trading Tracker

According to the SEC Form 4 filings, Lara Longpre has made a total of 6 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the sale of 847 shares on February 2, 2024, which brought Lara Longpre around $22,183.

Insider Trading History of Lara Longpre

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lara Longpre Trading Performance

GuruFocus tracks the stock performance after each of Lara Longpre's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lara Longpre is -5.99%. GuruFocus also compares Lara Longpre's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lara Longpre within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lara Longpre's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lara Longpre

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.37 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.99 LIMIT LIMIT LIMIT LIMIT LIMIT

Lara Longpre Ownership Network

Ownership Network List of Lara Longpre

No Data

Ownership Network Relation of Lara Longpre

Insider Network Chart

Lara Longpre Owned Company Details

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Lara Longpre is the Chief Development Officer of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include Chief Financial Officer Eric Bjerkholt , Chief Operating Officer Peter Radovich , and SVP & Global Controller Jolanda Howe .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Lara Longpre made 4 insider transaction in Mirum Pharmaceuticals Inc (MIRM) with a net sale of 3,873. Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 10,305 shares made by Peter Radovich , a net sale of 8,137 shares made by Jolanda Howe , and a net purchase of 161,963 shares made by Patrick J Heron .

In summary, during the past 3 months, insiders sold 4,303 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 4,000 shares, with a net sale of 303 shares. During the past 18 months, 93,444 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 175,963 shares were bought by its insiders, resulting in a net purchase of 82,519 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

Lara Longpre Mailing Address

Above is the net worth, insider trading, and ownership report for Lara Longpre. You might contact Lara Longpre via mailing address: C/o Mirum Pharmaceuticals, Inc., 950 Tower Lane, Suite 1050, Foster City Ca 94404.

Discussions on Lara Longpre

No discussions yet.